Cargando…

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine

Detalles Bibliográficos
Autores principales:	Benotmane, Ilies, Gautier-Vargas, Gabriela, Cognard, Noëlle, Olagne, Jérôme, Heibel, Françoise, Braun-Parvez, Laura, Martzloff, Jonas, Perrin, Peggy, Moulin, Bruno, Fafi-Kremer, Samira, Caillard, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055921/ https://www.ncbi.nlm.nih.gov/pubmed/33887315 http://dx.doi.org/10.1016/j.kint.2021.04.005

Ejemplares similares

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study
por: Benotmane, Ilies, et al.
Publicado: (2022)

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
por: Benotmane, Ilies, et al.
Publicado: (2022)

COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report
por: Cognard, Noëlle, et al.
Publicado: (2021)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2022)

Molecular evolution of the SARS-CoV-2 omicron BA.2 variant in kidney transplant recipients with prolonged viral shedding
por: Caillard, Sophie, et al.
Publicado: (2023)

Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
por: Benotmane, Ilies, et al.
Publicado: (2022)

Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study
por: Muller, Clotilde, et al.
Publicado: (2016)

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
por: Charmetant, Xavier, et al.
Publicado: (2022)

Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab
por: Gautier-Vargas, Gabriela, et al.
Publicado: (2020)

Prédiction de la sévérité de la COVID-19 par les biomarqueurs du syndrome de relargage cytokinique au sein d’une population de transplantés rénaux
por: Benotmane, I., et al.
Publicado: (2020)

Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia
por: Solis, Morgane, et al.
Publicado: (2022)

Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
por: Perrin, Peggy, et al.
Publicado: (2021)

A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
por: Masset, Christophe, et al.
Publicado: (2022)

Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
por: Lanfranco, Luca, et al.
Publicado: (2017)

Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis
por: Perrin, Peggy, et al.
Publicado: (2021)

In Reply to “Letter Regarding ‘Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis’”
por: Perrin, Peggy, et al.
Publicado: (2022)

L’immunosuppression et le défaut d’immunogénicité des vaccins à ARNm limitent la protection des patients transplantés vaccinés selon le schéma standard : plaidoyer pour une 3(e) dose
por: Charmetant, X., et al.
Publicado: (2021)

Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism
por: Felten, Renaud, et al.
Publicado: (2019)

Complications neurologiques du COVID-19 chez les patients atteints de maladie rénale
por: Perrin, P., et al.
Publicado: (2020)

Occurrence of De novo Donor-Specific Antibodies After COVID-19 in Kidney Transplant Recipients Is Low Despite Immunosuppression Modulation
por: Masset, Christophe, et al.
Publicado: (2022)

Atteintes rénales au cours de l’infection à SARS-Cov-2 : corrélations anatomocliniques
por: Olagne, J., et al.
Publicado: (2020)

Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies
por: Velay, Aurelie, et al.
Publicado: (2020)

Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients
por: Gallais, Floriane, et al.
Publicado: (2022)

Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report
por: Bahougne, Thibault, et al.
Publicado: (2020)

Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations?
por: Seeliger, Barbara, et al.
Publicado: (2020)

Adequacy between practice and European guidelines on hyponatremia: a survey among French nephrologists
por: Martzloff, Jonas, et al.
Publicado: (2022)

Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
por: Cuadrado, Antonio, et al.
Publicado: (2022)

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
por: Straus, Walter, et al.
Publicado: (2022)

Atypical focal segmental glomerulosclerosis associated with a new PODXL nonsense variant
por: Marx, David, et al.
Publicado: (2021)

Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination
por: Martinot, Martin, et al.
Publicado: (2021)

Antigen specificities of HIV-infected cells: A role in infection and persistence?
por: Faua, Clayton, et al.
Publicado: (2023)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

mrna-1273: Haematuria: 2 case reports
Publicado: (2021)

Adaptive Immunity to Hepatitis C Virus
por: Zeisel, Mirjam B., et al.
Publicado: (2009)

Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
por: Richards, Nathan E., et al.
Publicado: (2021)

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
por: Haller, Maria C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6os6bp2o6ht99v22i4slcrn31h